Attached files

file filename
8-K - FORM 8-K - AXON ENTERPRISE, INC.d430272d8k.htm

Exhibit 99.1

FOR RELEASE ON: October 26, 2012 at 7:30 a.m. ET

 

CONTACT:   

Dan Behrendt

Chief Financial Officer

TASER International, Inc.

(480) 905-2000

TASER Q3 Revenues Up 18% to $28.8 Million

$9.9 Million Cash From Operations & $5.3 million Operating Income

SCOTTSDALE, Ariz., October 26, 2012 — TASER International, Inc. (NASDAQ: TASR), today announced financial results for the third quarter of 2012 ended September 30, 2012.

Financial Summary:

 

   

Net sales were $28.8 million in the quarter, an increase of $4.4 million or 18.0% compared to third quarter 2011 sales of $24.4 million. The increase in sales versus the prior year was primarily driven by the extended upgrade program for the TASER® X2™ Electronic Control Device (ECD).

 

   

Revenues in the ECD business segment sequentially remained flat with the current quarter at $27.1 million in the third quarter of 2012. In comparison to the third quarter of 2011, revenues grew 15.9% in the third quarter of 2012.

 

   

Revenues in the video business segment increased 30.8% sequentially, from $1.3 million in the second quarter of 2012 to $1.7 million in the third quarter of 2012. In comparison to the third quarter of 2011, revenues grew 65.2% in the third quarter of 2012. AXON Flex™ on-officer cameras and EVIDENCE.com bookings continued to grow with bookings doubling sequentially from the second quarter of 2012 to the third quarter of 2012.

 

   

Gross margin in the third quarter of 2012 was 58.4%, compared to 53.7% in the same period last year. The improvement in gross margin was driven by the increase in sales and the realization of ongoing operational improvements and manufacturing efficiencies.

 

   

Operating income of $5.3 million benefited from the increased gross margins as well as lower R&D expenses versus the prior year. This was a significant increase from operating income in the third quarter of 2011 of $1.2 million.

 

   

Sales, general and administrative (SG&A) expenses of $9.5 million in the third quarter of 2012 increased 13.1% sequentially, from $8.4 million the second quarter of 2012. This increase was partially a result of higher variable selling expenses, including distributor overages, which resulted from increased direct sales and internet marketing initiatives.


The third quarter results also included discrete one-time expenses of $190,000 for additional stock compensation, severance and the costs associated with closing a remote facility. Personnel costs also increased sequentially as a result of annual salary merit increases and the payroll for additional strategic hires.

 

   

Research and development (R&D) expenses decreased $0.4 million to $2.0 million in the third quarter of 2012 when compared to the third quarter of 2011. The decrease was primarily attributable to the continued reduction in professional and consulting fees.

 

   

Adjusted operating income, which excludes the impact of stock-based compensation charges, depreciation and amortization and one-time litigation judgment expenses, was $7.8 million for the third quarter of 2012, a significant increase from an adjusted operating income of $4.0 million in the third quarter of 2011. GAAP income from operations was $5.3 million for the quarter, compared to income from operations of approximately $1.2 million for the third quarter of 2011.

 

   

Income taxes for the third quarter of 2012 were $1.6 million. The Company benefited from non-recurring adjustments relating to a return to provision adjustment and a rate differential true-up totaling approximately $0.5 million. The Company expects its annual effective tax rate to be approximately 40% for 2012.

 

   

Net income for the third quarter of 2012 was $3.7 million, or $0.07 per share on a basic and diluted basis.

 

   

In the third quarter of 2012, the Company generated $9.9 million in cash from operating activities. The Company generated $23.3 million in cash from operating activities in the first nine months of 2012.

 

   

Cash, cash equivalents and investments were $29.1 million at the end of the third quarter of 2012, after executing $3.9 million of stock repurchases during the quarter. The Company has no debt recorded on its balance sheet.

“We are encouraged by the growing momentum in our business as the X2 ECD continues to gain market traction and the installed based continues to transition to the X2,” commented Rick Smith, CEO of TASER International, Inc. “The Company also saw growth in the number of agencies embracing on-officer recording systems through sales of AXON Flex on-officer cameras and EVIDENCE.com service. Sequential bookings doubled this quarter and there is growing awareness in the marketplace about the value-add of these products. As a whole, these initiatives drove an 18% year-over-year growth in our top-line results.”

“Therefore, we have started to prudently reinvest into the business to fund future growth as evidenced by the uptick in SG&A expenses. We will look to tie this reinvestment directly with the sales and booking trends that we see in the future. We also continue to focus on creating a culture of operational excellence which has helped the Company deliver a third consecutive quarter of strong operational results, including significant cash generations of $9.9 million in the third quarter. We remain well positioned to deliver on the execution of our strategy to continue to generate significant operating cash flows, and to drive profitable growth and value for all of our stakeholders,” concluded Smith.


Other Significant Events:

 

   

In the third quarter, the Company continued to see adoption of the new X2 ECD platform by agencies through its extended upgrade program. The Company announced a number of significant orders that occurred during the third quarter, which included:

 

   

The Pima County Sheriff’s Office (AZ) purchased 600 X2 ECDs.

 

   

The Colorado Springs Police (CO) purchased 525 X2 ECDs.

 

   

The Indian River County Sheriff’s Department (FL) purchased 249 X2 ECDs.

 

   

The Orange County Sheriff’s Office (FL) purchased 400 X2 ECDs.

 

   

The Miami-Dade Police Department (FL) purchased 200 X2 ECDs.

 

   

The Company continued to see new agencies adopting the new TASER AXON Flex on-officer camera and EVIDENCE.com management service during the third quarter including:

 

   

The Pittsburgh Bureau of Police (PA) ordered 50 AXON Flex cameras with three full years of EVIDENCE.com.

 

   

The Chesapeake Police Department (MD) deployed 125 AXON Flex cameras with five years of EVIDENCE.COM.

 

   

The Hartford Police Department (CT) deployed 42 AXON Flex systems with one year of EVIDENCE.com.

 

   

The Topeka Police Department (KS) deployed 30 AXON Flex systems with three years of EVIDENCE.com.

 

   

The Wentzville Police Department (MO) deployed 30 AXON Flex systems with one year of EVIDENCE.com.

 

   

As previously announced, on April 25, 2012, the Board of Directors of TASER authorized a new share repurchase program for up to $20.0 million of its common stock, reflecting the Company’s strong balance sheet and operating cash flow generation. As of September 30, 2012, the Company completed the program through the aggregate repurchase of 6.8% of shares outstanding totaling 3,807,606 shares of stock costing approximately $20.0 million. This was done at an average price of roughly $5.22 per share. In the past twenty-one months, the Company has repurchased a total of 11,272,189 shares or 18.7% of the total shares outstanding at the start of the buyback programs. At September 30, 2012, the Company had 52,331,988 shares outstanding.

The Company will host its third quarter 2012 earnings conference call on Friday, October 26, 2012 at 11:00 a.m. ET. To join the live audio presentation, please dial toll free at 866-543-6407 or 617-213-8898 for international callers. The pass code is 27220415.


Non-GAAP Measures

To supplement the Company’s Statements of Operations presented in accordance with GAAP, we are presenting non-GAAP measures of certain components of financial performance. We have presented these measures for our investors to be better able to compare our current results with those of previous periods and have shown a reconciliation of GAAP to the non-GAAP financial measures in the tables at the end of this release. These non-GAAP measures include the impact of non-cash stock-based compensation expense, depreciation and amortization, litigation judgment expense, asset impairment charges and loss on write down of property and equipment. We use these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance by excluding certain expenses and expenditures that may not be indicative of our “recurring core business operating results,” meaning our operating performance excluding non-cash charges, such as stock-based compensation, depreciation and amortization and other discrete non-cash charges that are infrequent in nature. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management’s internal comparisons to our historical performance and liquidity.

Caution on Use of Non-GAAP Measures

As noted previously, these non-GAAP financial measures are not consistent with GAAP because they do not reflect the impact of other non-cash charges. Management believes investors will benefit from greater transparency in referring to these non-GAAP financial measures when assessing the Company’s operating results, as well as when forecasting and analyzing future periods. However, management recognizes that:

 

  these non-GAAP financial measures are limited in their usefulness and should be considered only as a supplement to the Company’s GAAP financial measures;
  these non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Company’s GAAP financial measures;
  these non-GAAP financial measures should not be considered to be superior to the Company’s GAAP financial measures; and
  these non-GAAP financial measures were not prepared in accordance with GAAP and investors should not assume that the non-GAAP financial measures presented in this earnings release were prepared under a comprehensive set of rules or principles.

Further, these non-GAAP financial measures may be unique to the Company, as they may be different from non-GAAP financial measures used by other companies. As such, this presentation of non-GAAP financial measures may not enhance the comparability of the Company’s results to the results of other companies.

A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure or measures appears at the end of this press release.


About TASER International, Inc.

TASER International, Inc. (NASDAQ:TASR) is a global provider of safety technologies that protect life and prevent conflict. More than 16,880 public safety agencies in 107 countries rely on TASER® electronic control devices and AXON on-officer camera systems to help protect and serve. Today, the use of TASER ECDs has saved more than 97,000 lives from potential death or serious injury while TASER innovations benefit individuals and families too, providing personal protection and accountability while maintaining regard for life. Since 1994, more than 251,000 individuals have relied on TASER technology as a means for effective personal safety. Learn more about TASER International and its solutions at www.TASER.com and www.EVIDENCE.com or by calling (800) 978-2737. Be a part of the TASER community by joining us on Facebook, LinkedIn, Twitter, and YouTube.

TASER® is a registered trademark of TASER International, Inc., registered in the U.S. All rights reserved. TASER logo, AXON, AXON Flex, X26, and X2 are trademarks of TASER International, Inc.

Note to Investors

To review the TASER International Safe Harbor Statement, please visit:

http://investor.taser.com/phoenix.zhtml?c=129937&p=irol-safeharbor.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including statements, without limitation, regarding our expectations, beliefs, intentions or strategies regarding the future. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking information is based upon current information and expectations regarding TASER International, Inc. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance, and involve certain risks, uncertainties and assumptions that are difficult to predict. Such forward-looking statements relate to: expected revenue and earnings growth; estimations regarding the size of our target markets; successful penetration of the law enforcement market; expansion of product sales to the private security, military and consumer self-defense markets; growth expectations for new and existing accounts; expansion of production capability; new product introductions; product safety and our business model. We caution that these statements are qualified by important factors that could cause actual results to differ materially from those reflected by the forward-looking statements herein.


TASER International assumes no obligation to update the information contained in this press release. These statements are qualified by important factors that could cause our actual results to differ materially from those reflected by the forward-looking statements. Such factors include but are not limited to: (1) market acceptance of our products; (2) our ability to establish and expand direct and indirect distribution channels; (3) our ability to attract and retain the endorsement of key opinion-leaders in the law enforcement community; (4) the level of product technology and price competition for our products; (5) the degree and rate of growth of the markets in which we compete and the accompanying demand for our products; (6) risks associated with rapid technological change and new product introductions; (7) competition; (8) litigation including lawsuits resulting from alleged product related injuries and death; (9) media publicity concerning allegations of deaths and injuries occurring after use of the TASER device and the negative effect this publicity could have on our sales; (10) TASER device tests and reports; (11) product quality; (12) implementation of manufacturing automation; (13) potential fluctuations in our quarterly operating results; (14) financial and budgetary constraints of prospects and customers; (15) potential delays in international and domestics orders; (16) dependence upon sole and limited source suppliers; (17) negative reports concerning the TASER device; (18) fluctuations in component pricing; (19) government regulations and inquiries; (20) dependence upon key employees and our ability to retain employees; (21) execution and implementation risks of new technology; (22) ramping manufacturing production to meet demand; (23) medical and safety studies; (24) field test results; and (25) other factors detailed in our filings with the Securities and Exchange Commission, including, without limitation, those factors detailed in the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q.

For investor relations information please contact Erin Curtis by phone at 480-515-6330 or via email at IR@TASER.com, or Dan Behrendt, Chief Financial Officer of TASER International, Inc., 480-905-2002.

- more -


TASER International, Inc.

Consolidated Statements of Operations

(Unaudited)

 

     For the Three Months Ended  
     September 30, 2012      September 30, 2011  

Net sales

   $ 28,772,956       $ 24,383,110   

Cost of products sold

     11,969,944         11,279,502   
  

 

 

    

 

 

 

Gross margin

     16,803,012         13,103,608   

Sales, general and administrative expenses

     9,539,996         9,477,548   

Research and development expenses

     1,985,701         2,362,721   

Asset impairment

     —           3,353   

Loss on write down / disposal of property and equipment, net

     —           47,894   
  

 

 

    

 

 

 

Income from operations

     5,277,315         1,212,092   

Interest and other income, net

     11,418         15,265   
  

 

 

    

 

 

 

Income before provision for income taxes

     5,288,733         1,227,357   

Provision for income taxes

     1,611,861         91,072   
  

 

 

    

 

 

 

Net income

   $ 3,676,872       $ 1,136,285   
  

 

 

    

 

 

 

Income per common and common equivalent shares

     

Basic

   $ 0.07       $ 0.02   

Diluted

   $ 0.07       $ 0.02   

Weighted average number of common and common equivalent shares outstanding

     

Basic

     52,509,068         58,787,274   

Diluted

     53,106,325         60,037,328   


TASER International, Inc.

Consolidated Statements of Operations

(Unaudited)

 

     For the Nine Months Ended  
     September 30, 2012     September 30, 2011  

Net sales

   $ 82,636,791      $ 68,698,115   

Cost of products sold

     34,090,148        31,145,151   
  

 

 

   

 

 

 

Gross margin

     48,546,643        37,552,964   

Sales, general and administrative expenses

     26,798,629        27,887,357   

Research and development expenses

     6,156,751        7,908,420   

Litigation judgment expense

     (2,200,000     3,301,243   

Asset impairment

     —          1,353,857   

Loss on write down / disposal of property and equipment, net

     —          796,353   
  

 

 

   

 

 

 

Income (loss) from operations

     17,791,263        (3,694,266

Interest and other income, net

     25,545        1,303,470   
  

 

 

   

 

 

 

Income (loss) before provision for income taxes

     17,816,808        (2,390,796

Provision (benefit) for income taxes

     6,893,872        (1,251,981
  

 

 

   

 

 

 

Net income (loss)

   $ 10,922,936      $ (1,138,815
  

 

 

   

 

 

 

Income (loss) per common and common equivalent shares

    

Basic

   $ 0.19      $ (0.02

Diluted

   $ 0.19      $ (0.02

Weighted average number of common and common equivalent shares outstanding

    

Basic

     57,997,341        60,617,787   

Diluted

     58,482,833        60,617,787   


TASER International, Inc.

Segment Reporting

(Unaudited)

 

     For the Three Months Ended  
     September 30, 2012     September 30, 2011  
     Video     ECD     Total     Video     ECD     Total  

Product sales

   $ 1,528,347      $ 27,085,180      $ 28,613,527      $ 925,836      $ 23,361,182      $ 24,287,018   

Service revenue

     159,429        —          159,429        96,092        —          96,092   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net sales

     1,687,776        27,085,180        28,772,956        1,021,928        23,361,182        24,383,110   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cost of products sold

     1,181,906        9,673,370        10,855,276        693,278        9,437,149        10,130,427   

Cost of service delivered

     1,114,668        —          1,114,668        1,149,075        —          1,149,075   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of sales

     2,296,574        9,673,370        11,969,944        1,842,353        9,437,149        11,279,502   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

     (608,798     17,411,810        16,803,012        (820,425     13,924,033        13,103,608   

Sales, general and administrative expenses

     921,746        8,618,250        9,539,996        730,275        8,747,273        9,477,548   

Research and development expenses

     942,094        1,043,607        1,985,701        1,195,250        1,167,471        2,362,721   

Asset impairment

     —          —          —          —          3,353        3,353   

Loss on write down / disposal of property and equipment, net

     —          —          —          —          47,894        47,894   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income from operations

   $ (2,472,638   $ 7,749,953      $ 5,277,315      $ (2,745,950   $ 3,958,042      $ 1,212,092   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income from operations, normalized

   $ (2,472,638   $ 7,749,953      $ 5,277,315      $ (2,745,950   $ 4,009,289      $ 1,263,339   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating margin %

     -147     29     18     -269     17     5

Operating margin %, normalized

     -147     29     18     -269     17     5

 

     For the Nine Months Ended  
     September 30, 2012     September 30, 2011  
     Video     ECD     Total     Video     ECD     Total  

Product sales

   $ 3,464,606      $ 78,774,581      $ 82,239,187      $ 2,420,960      $ 66,025,172      $ 68,446,132   

Service revenue

     397,604        —          397,604        251,983        —          251,983   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net sales

     3,862,210        78,774,581        82,636,791        2,672,943        66,025,172        68,698,115   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cost of products sold

     2,712,678        28,068,676        30,781,354        1,955,722        25,686,372        27,642,094   

Cost of service delivered

     3,308,794        —          3,308,794        3,503,057        —          3,503,057   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of sales

     6,021,472        28,068,676        34,090,148        5,458,779        25,686,372        31,145,151   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

     (2,159,262     50,705,905        48,546,643        (2,785,836     40,338,800        37,552,964   

Sales, general and administrative expenses

     2,425,228        24,373,401        26,798,629        2,270,006        25,617,351        27,887,357   

Research and development expenses

     3,350,708        2,806,043        6,156,751        3,422,452        4,485,968        7,908,420   

Litigation judgment expense

     —          (2,200,000     (2,200,000     —          3,301,243        3,301,243   

Asset impairment

     —          —          —          —          1,353,857        1,353,857   

Loss on write down / disposal of property and equipment, net

     —          —          —          711,243        85,110        796,353   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income from operations

   $ (7,935,198   $ 25,726,461      $ 17,791,263      $ (9,189,537   $ 5,495,271      $ (3,694,266
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income from operations, normalized

   $ (7,935,198   $ 23,526,461      $ 15,591,263      $ (8,478,294   $ 10,235,481      $ 1,757,187   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating margin %

     -205     33     22     -344     8     -5

Operating margin %, normalized

     -205     30     19     -317     16     3


TASER International, Inc.

Reconciliation of GAAP to Non-GAAP Financial Measures

(Unaudited)

 

     For the Three Months Ended  
     September 30, 2012      September 30, 2011  
     Video     ECD      Total      Video     ECD      Total  

GAAP (loss) income from operations

   $ (2,472,638   $ 7,749,953       $ 5,277,315       $ (2,745,950   $ 3,958,042       $ 1,212,092   

Stock-based compensation expense (a)

     99,179        750,211         849,390         81,747        611,773         693,520   

Depreciation and amortization

     664,307        1,054,239         1,718,546         663,527        1,331,505         1,995,032   

Asset impairment

     —          —           —           —          3,353         3,353   

Loss on write down / disposal of property and equipment, net

     —          —           —           —          47,894         47,894   
  

 

 

   

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Adjusted operating (loss) income

   $ (1,709,152   $ 9,554,403       $ 7,845,251       $ (2,000,676   $ 5,952,567       $ 3,951,891   
  

 

 

   

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

 

a) Results include stock-based compensation as follows:

 

     For the Three Months Ended  
     September 30, 2012      September 30, 2011  

Cost of products sold

   $ 38,085       $ 30,238   

Sales, general and administrative expenses

     657,870         518,513   

Research and development expenses

     153,435         144,769   
  

 

 

    

 

 

 
   $ 849,390       $ 693,520   
  

 

 

    

 

 

 

 

    For the Nine Months Ended  
    September 30, 2012     September 30, 2011  
    Video     ECD     Total     Video     ECD     Total  

GAAP (loss) income from operations

  $ (7,935,198   $ 25,726,461      $ 17,791,263      $ (9,189,537   $ 5,495,271      $ (3,694,266

Stock-based compensation expense (a)

    285,292        1,851,209        2,136,501        309,114        2,224,330        2,533,444   

Depreciation and amortization

    1,777,586        3,336,403        5,113,989        1,977,570        4,135,042        6,112,612   

Litigation judgment expense

    —          (2,200,000     (2,200,000     —          3,301,243        3,301,243   

Asset impairment

    —          —          —          —          1,353,857        1,353,857   

Loss on write down / disposal of property and equipment, net

    —          —          —          —          796,353        796,353   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted operating (loss) income

  $ (5,872,320   $ 28,714,073      $ 22,841,753      $ (6,902,853   $ 17,306,096      $ 10,403,243   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

a) Results include stock-based compensation as follows:

 

     For the Nine Months Ended  
     September 30,
2012
     September 30,
2011
 

Cost of products sold

   $ 100,248       $ 135,217   

Sales, general and administrative expenses

     1,614,160         1,891,258   

Research and development expenses

     422,093         506,969   
  

 

 

    

 

 

 
   $ 2,136,501       $ 2,533,444   
  

 

 

    

 

 

 


TASER International, Inc.

Consolidated Balance Sheets

(Unaudited)

 

     September 30, 2012     December 31, 2011  
ASSETS   

Current Assets:

    

Cash and cash equivalents

   $ 25,965,711      $ 21,300,733   

Short-term investments

     3,178,050        5,108,189   

Accounts receivable, net of allowance of $325,000 and $450,000 at September 30, 2012 and December 31, 2011, respectively

     14,551,275        11,780,135   

Inventory

     10,430,832        11,484,761   

Prepaid expenses and other current assets

     2,268,761        2,089,676   

Deferred income tax assets, net

     7,082,926        9,968,929   
  

 

 

   

 

 

 

Total current assets

     63,477,555        61,732,423   

Property and equipment, net

     22,650,797        26,845,220   

Deferred income tax assets, net

     12,716,169        12,716,169   

Intangible assets, net

     3,332,276        3,224,006   

Other long-term assets

     409,940        444,933   
  

 

 

   

 

 

 

Total assets

   $ 102,586,737      $ 104,962,751   
  

 

 

   

 

 

 
LIABILITIES AND STOCKHOLDERS’ EQUITY   

Current Liabilities:

    

Accounts payable

   $ 4,259,347      $ 4,513,938   

Accrued liabilities

     8,929,766        7,643,004   

Current portion of deferred revenue

     3,898,535        3,317,641   

Customer deposits

     327,640        413,314   
  

 

 

   

 

 

 

Total current liabilities

     17,415,288        15,887,897   

Deferred revenue, net of current portion

     6,649,519        4,636,901   

Liability for unrecorded tax benefits

     2,206,551        1,982,399   
  

 

 

   

 

 

 

Total liabilities

     26,271,358        22,507,197   
  

 

 

   

 

 

 

Commitments and Contingencies

    

Stockholders’ Equity

    

Preferred stock, $0.00001 par value per share; 25 million shares authorized; no shares issued and outstanding at September 30, 2012 and December 31, 2011, respectively

     —          —     

Common stock, $0.00001 par value per share; 200 million shares authorized; 52,331,988 and 55,696,608 shares issued and outstanding at September 30, 2012 and December 31, 2011, respectively

     657        652   

Additional paid-in capital

     104,525,144        101,597,626   

Treasury stock, 13,363,789 and 2,091,600 shares at September 30, 2012 and December 31, 2011, respectively

     (67,203,043     (47,207,093

Retained earnings

     39,068,261        28,145,325   

Accumulated other comprehensive loss

     (75,640     (80,956
  

 

 

   

 

 

 

Total stockholders’ equity

     76,315,379        82,455,554   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 102,586,737      $ 104,962,751   
  

 

 

   

 

 

 


TASER International, Inc.

Selected Consolidated Statement of Cash Flows Information

(Unaudited)

 

     For the Nine Months Ended  
     September 30, 2012     September 30, 2011  

Net income (loss)

   $ 10,922,936      $ (1,138,815

Depreciation and amortization

     5,113,989        6,112,612   

Stock-based compensation expense

     2,136,501        2,533,444   

Net cash provided by operating activities

     23,258,163        14,637,384   

Net cash provided by (used in) investing activities

     676,690        (7,813,187

Net cash used in financing activities

     (19,265,477     (24,845,271

Cash and cash equivalents, end of period

     25,965,711        24,574,858